The median time to NB progression or recurrence was 13.2 months; the median time to recurrence was 11 months in 562 patients with MYCN amplification and 14.5 months in 1141 patients with no MYCN amplification, with a significant difference noted between the two groups (P <  0.05). This evidence concerns the gene MYCN and neuroblastoma.